Articles From: L.B. Foster Company to Report Third Quarter 2014 Operating Results on November 4, 2014 to LabCorp to Acquire Covance for Approximately $5.6 Billion, Creating World’s Leading Healthcare Diagnostics Company


PITTSBURGH, Pa., Oct.
Sign-up for L.B. Foster Company to Report Third Quarter 2014 Operating Results on November 4, 2014 investment picks
PITTSBURGH, Nov.
Sign-up for L.B. Foster Reports Third Quarter Operating Results investment picks
2014/11/27
By Jason Chow PARIS--L'Oreal SA (OR.FR) and Nestle SA (NESN.VX) announced Thursday it would end its Inneov joint venture, a project to develop and sell nutritional beauty supplements, in the first quarter of 2015.
Sign-up for L'Oreal and Nestle Close Joint Venture Inneov investment picks
Demandware ® , Inc. (NYSE:DWRE), the industry-leading provider of enterprise cloud commerce solutions, and L2, Inc. , a member-based business intelligence service that benchmarks the digital competence of brands, today announced the release of a new report that examines the efforts of 80 global brands to produce and syndicate content across the consumer shopping experience.
Sign-up for L2 and Demandware Release New Global Study on Content & Commerce investment picks
2014/11/25
By Susan Carey Dreamjet SAS, which started flying in July between Paris and Newark, N.J., under the brand name La Compagnie, plans to bring its aggressively priced business-class fares to the New York-London route this spring, according to Chief Executive Frantz Yvelin.
Sign-up for La Compagnie Will Add NY-London to its NY-Paris Offering in March investment picks
National Beverage Corp.
Sign-up for La Croix ‘Sparkles’ National Beverage Corp.’s First Half Performance investment picks
LA Fitness and Healthways, Inc. (NASDAQ: HWAY) announced today that LA Fitness will begin welcoming members of the award-winning SilverSneakers ® Fitness and Prime ® Fitness programs at nearly 600 of its locations nationwide by early 2015.
Sign-up for LA Fitness to Welcome Healthways SilverSneakers And Prime Fitness Members investment picks
La Jolla Pharmaceutical Company (Nasdaq: LJPC) (the Company or La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases, and the George Washington University (GW), today announced that La Jolla and GW have entered into an exclusive worldwide license agreement for GW intellectual property rights covering the use of angiotensin II for the therapeutic treatment of patients with hypotension and shock.
Sign-up for La Jolla Pharmaceutical Company and the George Washington University Announce Exclusive Worldwide License Agreement investment picks
La Jolla Pharmaceutical Company (Nasdaq: LJPC) (“the Company” or “La Jolla”), a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases, today announced that an abstract of the results for the Company’s Phase 2 clinical trial of GCS-100 in chronic kidney disease (CKD) has been selected by the American Society of Nephrology’s (ASN) Program Committee for poster presentation at the Kidney Week Annual Meeting.
Sign-up for La Jolla Pharmaceutical Company Announces Data Presentation at the American Society of Nephrology Kidney Week investment picks
La Jolla Pharmaceutical Company (NASDAQ: LJPC) (the Company or La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases, today reported third quarter and year-to-date 2014 financial results and highlighted recent corporate progress and near-term milestones.
Sign-up for La Jolla Pharmaceutical Company Announces Third Quarter and Year-to-Date 2014 Financial Results and Corporate Highlights investment picks
MicroStrategy Mobile App Gives Luxury Brand a Strategic Edge in Business TYSONS CORNER, Va.
Sign-up for La Perla Embraces MicroStrategy as its Mobile Analytics Enterprise Standard investment picks
2014/11/17
IRVING, Texas , Nov.
Sign-up for La Quinta Announces Secondary Offering of 20,000,000 Shares of Common Stock investment picks
2014/11/25
IRVING, Texas , Nov.
Sign-up for La Quinta Completes $460 Million Secondary Offering investment picks
2014/12/2
Mit Shah Appointed Chairman IRVING, Texas , Dec.
Sign-up for La Quinta Holdings Inc. Announces Board Appointment investment picks
- Generated RevPAR Growth of 8.9% - Achieved Pro forma Adjusted EBITDA Growth of 13.6% - Increases Full Year 2014 Guidance IRVING, Texas , Oct.
Sign-up for La Quinta Holdings Inc. Reports Strong Third Quarter 2014 Results investment picks
2014/10/8
IRVING, Texas , Oct.
Sign-up for La Quinta Holdings To Report Third Quarter 2014 Earnings And Host Conference Call investment picks
2014/11/19
IRVING, Texas , Nov.
Sign-up for La Quinta Prices Secondary Offering investment picks
Innovative Australian University is the World's First SAP® Simple Finance Solution Customer MELBOURNE, Australia , Oct.
Sign-up for La Trobe University Brings the Simplicity of SAP® Cloud powered by SAP HANA® to Students and Staff investment picks
MONROE, Mich.
Sign-up for La-Z-Boy Announces Fiscal 2015 Second-Quarter Conference Call investment picks
2014/11/18
La-Z-Boy Inc. shares surged more than 4% in after-hours trade Tuesday, after the furniture maker reported better-than-expected fiscal second-quarter earnings and announced a dividend hike.
Sign-up for La-Z-Boy shares up 4% as profit tops estimates, raises dividend investment picks
By Michael Calia Laboratory Corp.
Sign-up for LabCorp agrees to buy Covance for about $5.94 billion investment picks
2014/12/5
Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) today announced the completion of its acquisition of Bode Technology Group, Inc., (Bode Technology) from SolutionPoint International, Inc. As a wholly-owned subsidiary of LabCorp, Bode Technology and its division Chromosomal Labs will continue to provide specialized forensic DNA analysis, proprietary DNA collection products, and relationship testing to an international market in combination with LabCorp’s US- and UK-based DNA Identity and Cellmark Forensics businesses, part of LabCorp’s Specialty Testing Group.
Sign-up for LabCorp Announces Acquisition of Bode Technology investment picks
Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE:LH) and LipoScience, Inc. (NASDAQ:LPDX), a provider of specialized cardiovascular diagnostic laboratory tests based on nuclear magnetic resonance (NMR) technology, today announced that they entered into a definitive merger agreement under which LabCorp would acquire LipoScience for a purchase price of $5.25 per share in cash, or a transaction value of $85.3 million which represents a total enterprise value of approximately $63 million.
Sign-up for LabCorp Announces Agreement to Acquire LipoScience investment picks
Acquisition Price of $5.25 Per Share in All Cash Transaction NMR LipoProfile test expands LabCorp's offering of personalized diagnostic tests BURLINGTON, N.C., Sept.
Sign-up for LabCorp Announces Agreement to Acquire LipoScience investment picks
Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) today announced the completion of its acquisition of LIPOSCIENCE, Inc. (NASDAQ:LPDX), effective November 20, 2014.
Sign-up for LabCorp Completes Acquisition of LIPOSCIENCE investment picks
Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) and Monogram Biosciences, Inc., part of the LabCorp Specialty Testing Group, today announced the launch of HIV GenoSure Archive SM , the first laboratory test to help optimize antiretroviral (ARV) drug regimens in virally suppressed HIV patients.
Sign-up for LabCorp Introduces HIV-1 Next Generation Sequencing Assay to Support Drug Regimen Changes in HIV Suppressed Patients investment picks
Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) and Covance Inc. (NYSE: CVD) today announced that they have entered into a definitive agreement under which LabCorp will acquire Covance for cash and LabCorp shares currently valued at $105.12 per Covance share, or an equity value of approximately $6.1 billion and an enterprise value of approximately $5.6 billion.
Sign-up for LabCorp to Acquire Covance for Approximately $5.6 Billion, Creating World’s Leading Healthcare Diagnostics Company investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: L.B. Foster Company to Report Third Quarter 2014 Operating Results on November 4, 2014 to LabCorp to Acquire Covance for Approximately $5.6 Billion, Creating World’s Leading Healthcare Diagnostics Company
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent